These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10384833)

  • 1. Early use of coronary angiography and intervention.
    McCullough PA; O'Neill WW
    Cardiol Clin; 1999 May; 17(2):373-86. PubMed ID: 10384833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction.
    Cannon CP; Weintraub WS; Demopoulos LA; Robertson DH; Gormley GJ; Braunwald E
    Am J Cardiol; 1998 Sep; 82(6):731-6. PubMed ID: 9761082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of an early invasive management strategy in women with acute coronary syndromes.
    Glaser R; Herrmann HC; Murphy SA; Demopoulos LA; DiBattiste PM; Cannon CP; Braunwald E
    JAMA; 2002 Dec; 288(24):3124-9. PubMed ID: 12495392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina.
    Benamer H; Steg PG; Benessiano J; Vicaut E; Gaultier CJ; Aubry P; Boudvillain O; Sarfati L; Brochet E; Feldman LJ; Himbert D; Juliard JM; Assayag P
    Am Heart J; 1999 May; 137(5):815-20. PubMed ID: 10220629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
    Stone GW; Bertrand M; Colombo A; Dangas G; Farkouh ME; Feit F; Lansky AJ; Lincoff AM; Mehran R; Moses JW; Ohman M; White HD
    Am Heart J; 2004 Nov; 148(5):764-75. PubMed ID: 15523305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive versus conservative therapy in unstable angina.
    Lange RA; Hillis LD
    Cardiol Clin; 1999 May; 17(2):387-99, x. PubMed ID: 10384834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial.
    Morrow DA; Cannon CP; Rifai N; Frey MJ; Vicari R; Lakkis N; Robertson DH; Hille DA; DeLucca PT; DiBattiste PM; Demopoulos LA; Weintraub WS; Braunwald E;
    JAMA; 2001 Nov; 286(19):2405-12. PubMed ID: 11712935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Ischemia-guided" versus "early invasive" strategies in the management of acute coronary syndrome/non-ST-segment elevation myocardial infarction: the interventionalist's perspective.
    McKay RG
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):96S-102S. PubMed ID: 12644347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of unstable coronary syndromes in patients with previous coronary artery bypass grafts following coronary angiography.
    Chan AW; Ross J
    Clin Invest Med; 1997 Oct; 20(5):320-6. PubMed ID: 9336657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.
    Rajagopal V; Lincoff AM; Cohen DJ; Gurm HS; Hu T; Desmet WJ; Kleiman NS; Bittl JA; Feit F; Topol EJ
    Am Heart J; 2006 Jul; 152(1):149-54. PubMed ID: 16824845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
    Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
    J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
    Circulation; 1997 Sep; 96(5):1445-53. PubMed ID: 9315530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Routine invasive" versus "selective invasive" approaches to non-ST-segment elevation acute coronary syndromes management in the post-stent/platelet inhibition era.
    Boden WE
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):113S-122S. PubMed ID: 12644349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous transluminal angioplasty of saphenous vein grafts for medically refractory unstable angina.
    Morrison DA; Crowley ST; Veerakul G; Barbiere CC; Grover F; Sacks J
    J Am Coll Cardiol; 1994 Apr; 23(5):1066-70. PubMed ID: 8144769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy.
    Ronner E; Boersma E; Laarman GJ; Somsen GA; Harrington RA; Deckers JW; Topol EJ; Califf RM; Simoons ML
    J Am Coll Cardiol; 2002 Jun; 39(12):1924-9. PubMed ID: 12084589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.
    Stone GW; Bertrand ME; Moses JW; Ohman EM; Lincoff AM; Ware JH; Pocock SJ; McLaurin BT; Cox DA; Jafar MZ; Chandna H; Hartmann F; Leisch F; Strasser RH; Desaga M; Stuckey TD; Zelman RB; Lieber IH; Cohen DJ; Mehran R; White HD;
    JAMA; 2007 Feb; 297(6):591-602. PubMed ID: 17299194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of early percutaneous coronary intervention in patients with Braunwald III-B type unstable angina pectoris].
    Nozaki K; Nakao K; Horiuchi K; Kasanuki H; Honda T
    J Cardiol; 2003 Jun; 41(6):263-70. PubMed ID: 12845880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors easily obtained at presentation predict resource utilization in unstable angina.
    Calvin JE; Klein LW; VandenBerg BJ; Meyer P; Ramirez-Morgen LM; Parrillo JE
    Am Heart J; 1998 Sep; 136(3):373-81. PubMed ID: 9736126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interventional therapy in unstable angina pectoris].
    Meier B
    Praxis (Bern 1994); 1995 Feb; 84(8):225-31. PubMed ID: 7886361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.